Sign in
Abicipar Phase 2 MAPLE Trial Supports Improved Safety for Patients with nAMD Following a Modified Manufacturing Process
Raj K. Maturi, MD
Updates from the Field
2019
Pradeepa Yoganathan Last Word
Pradeepa Yoganathan, MSc, MD, FRCS(C)
Annual Meeting Talks
Diabetic Retinopathy Progression in Anti-VEGF versus Fluocinolone Acetonide Implant Treated Eyes Who are Lost to Follow-up
Caesar K. Luo, MD, FASRS
2020
Category: Diabetic Retinopathy